Filtros de búsqueda

Lista de obras de Andy C Rawstron

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

artículo científico publicado en 2015

A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma

artículo científico publicado en 2004

A molecular study of the t(4;14) in multiple myeloma

artículo científico publicado en 2002

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

artículo científico publicado en 1997

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

artículo científico publicado en 2011

A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma

artículo científico publicado en 2007

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

artículo científico publicado en 2014

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial

artículo científico publicado en 2012

An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial

artículo científico publicado en 2014

Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve

artículo científico publicado en 2001

Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma

artículo científico publicado en 2010

Assessing minimal residual disease in chronic lymphocytic leukemia

scientific article published on January 2008

Assessment of IgH PCR strategies in multiple myeloma.

artículo científico publicado en 1996

Assessment of bone marrow response in Waldenström's macroglobulinemia

artículo científico publicado en 2009

Assessment of minimal residual disease in myeloma and the need for a consensus approach

artículo científico publicado en 2015

Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis ⬇️

artículo científico publicado en 2017

Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.

artículo científico publicado en 1998

B cell biomarkers of rituximab responses in systemic lupus erythematosus

artículo científico publicado en 2011

B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle

artículo científico publicado en 2007

B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors

artículo científico publicado en 1998

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

artículo científico publicado en 2004

CD4+CD25+FoxP3+regulatory T cells are increased whilst CD3+CD4−CD8−αβTCR+Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment

artículo científico publicado en 2005

CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy

artículo científico publicado en 2006

Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

artículo científico publicado en 2002

Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial ⬇️

artículo científico publicado en 2016

Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing

artículo científico publicado en 2010

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

artículo científico publicado en 1997

Circulating primitive stem cells in paroxysmal nocturnal hemoglobinuria (PNH) are predominantly normal in phenotype but granulocyte colony-stimulating factor treatment mobilizes mainly PNH stem cells.

artículo científico publicado en 1998

Clinical and diagnostic implications of monoclonal B-cell lymphocytosis

scientific article published on March 2010

Clinical cytometry in Europe, 2012

artículo científico publicado en 2012

Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients

artículo científico publicado en 2004

Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection

artículo científico publicado en 2010

Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

artículo científico publicado en 2015

Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

artículo científico publicado en 2015

Controversies surrounding the clonogenic origin of multiple myeloma

artículo científico publicado en 2000

Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?

scientific article published on 01 January 2007

DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma

artículo científico publicado en 2013

Defining IgM multiple myeloma

scholarly article by Roger G Owen et al published 14 July 2011 in American Journal of Hematology

Demonstration of a germinal center immunophenotype in lymphomas by immunocytochemistry and flow cytometry

artículo científico publicado en 2005

Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection.

artículo científico publicado en 1996

Diagnostic criteria for monoclonal B-cell lymphocytosis

artículo científico publicado en 2005

Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).

scientific article published on January 2010

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

scientific article published on 01 January 1999

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia

artículo científico publicado en 2003

Eradicating minimal residual disease in chronic lymphocytic leukemia: should this be the goal of treatment?

scientific article published on January 2010

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation ⬇️

artículo científico publicado en 2016

Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival

artículo científico publicado en 2005

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

artículo científico publicado en 2012

Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process

artículo científico publicado en 2006

Extramedullary plasmacytoma are characterized by a ‘myeloma-like’ immunophenotype and genotype and occult bone marrow involvement

scientific article published on 29 September 2010

Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course

artículo científico publicado en 2010

FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells.

artículo científico publicado en 1999

FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma

artículo científico publicado en 2012

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

artículo científico publicado en 2002

Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens

artículo científico publicado en 2006

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

scholarly article by Ola Landgren et al published 19 November 2014 in American Journal of Hematology

Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism

artículo científico publicado en 2003

Heterogeneity of Histological Transformation Events in Waldenström's Macroglobulinemia (WM) and Related Disorders

artículo científico publicado en 2011

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

artículo científico publicado en 2000

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

artículo científico publicado en 2008

Human peripheral blood B-cell compartments: a crossroad in B-cell traffic.

artículo científico publicado en 2010

Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells

artículo científico publicado en 2019

IgM myeloma with t(4;14)(p16;q32)

article

IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).

artículo científico publicado en 2008

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.

artículo científico publicado en 2013

Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells

artículo científico publicado en 2013

Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance

artículo científico publicado en 2006

Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).

artículo científico publicado en 1995

Immunophenotyping of plasma cells

artículo científico publicado en 2006

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.

artículo científico publicado en 2012

In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.

artículo científico publicado en 2001

In vitro generation of long-lived human plasma cells.

artículo científico publicado en 2012

Inherited genetic susceptibility to monoclonal B-cell lymphocytosis

artículo científico publicado en 2010

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance

artículo científico publicado en 2014

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

artículo científico publicado en 2002

Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma

artículo científico publicado en 2001

Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma

artículo científico publicado en 2001

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

artículo científico publicado en 2007

Is MRD eradication a desirable goal in CLL?

artículo científico publicado en 2010

Isotype class switching and the pathogenesis of multiple myeloma.

artículo científico publicado en 2002

Liposomal daunorubicin:in vitro andin vivo efficacy in multiple myeloma

artículo científico publicado en 1998

Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment

artículo científico publicado en 2010

Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service

artículo científico

Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study

artículo científico publicado en 2013

Minimal residual disease assessment in chronic lymphocytic leukaemia

artículo científico publicado en 2007

Minimal residual disease detection in myeloma: no more molecular remissions?

artículo científico publicado en 2005

Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

artículo científico publicado en 2015

Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction

artículo científico publicado en 2015

Minimal residual disease is an independent predictor for 10-year survival in CLL. ⬇️

artículo científico publicado en 2016

Minimal residual disease monitoring in multiple myeloma.

artículo científico publicado en 2002

Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice

artículo científico publicado en 2005

Mobilization of Philadelphia-negative peripheral blood mononuclear cells in chronic myeloid leukaemia using hydroxyurea and G-CSF (filgrastim).

artículo científico publicado en 1996

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

artículo científico publicado en 2005

Monoclonal B Cell Lymphocytosis—What Does It Really Mean? ⬇️

artículo científico publicado el 1 de marzo de 2013

Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

artículo científico publicado en 2002

Monoclonal B-cell lymphocytosis

artículo científico publicado en 2009

Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults

artículo científico publicado en 2006

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

artículo científico publicado en 2008

Monoclonal B-cell lymphocytosis: good news for patients and CLL investigators

artículo científico publicado en 2007

Occult B-cell lymphoproliferative disorders

artículo científico publicado en 2011

Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis

artículo científico publicado en 2014

Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience

artículo científico publicado en 2007

Overview of monoclonal B-cell lymphocytosis

artículo científico publicado en 2007

Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.

artículo científico publicado en 1996

Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

artículo científico publicado en 2000

Prevalence and characteristics of monoclonal B-cell lymphocytosis (MBL) in healthy individuals and the relationship with clinical disease.

artículo científico publicado en 2004

Prevalence of monoclonal B-cell lymphocytosis: a systematic review

artículo científico publicado en 2010

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

artículo científico publicado en 2001

Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al.

artículo científico publicado en 2009

Reduced-dose rituximab in rheumatoid arthritis: efficacy depends on degree of B cell depletion.

artículo científico publicado en 2011

Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions ⬇️

artículo científico publicado en 2015

Reply to M. Roschewski et al.

artículo científico publicado en 2014

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

artículo científico publicado en 2008

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

artículo científico publicado en 2018

Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

artículo científico publicado en 2012

Response to Dr Bredemeier's letter

artículo científico publicado en 2014

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL. ⬇️

artículo científico publicado en 2017

Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

article

Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study

artículo científico publicado en 2014

Serum siliac acid in patients with multiple myeloma

artículo científico publicado en 1997

Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab

article

TRUE SPECTRUM OF 14q32 TRANSLOCATIONS IN MULTIPLE MYELOMA

artículo científico publicado en 1998

Telomere length predicts for outcome to FCR chemotherapy in CLL

artículo científico publicado en 2019

Thalidomide maintenance following high-dose therapy in multiple myeloma: a UK myeloma forum phase 2 study

artículo científico publicado en 2007

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells

artículo científico publicado en 2014

The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment.

artículo científico publicado en 1999

The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia

artículo científico publicado en 2007

The bone marrow microenvironment influences the differential chemokine receptor expression of normal and neoplastic plasma cells

scientific article published on 01 June 2005

The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma

artículo científico publicado en 2001

The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells.

artículo científico publicado en 2000

Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

article

Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination

artículo científico publicado en 2004

Translocation t(14;16) in IgM multiple myeloma

artículo científico publicado en 2011

p53 gene mutations in multiple myeloma.

artículo científico publicado en 1997

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda